Sign in Subscribe

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised

The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
Credit: Lantheus Holdings
Already have an account? Sign in.